Clinical bottom line
Postoperative venous thromboembolism (VTE) prophylaxis remains a critical component of perioperative care in general surgery to reduce morbidity and mortality associated with deep vein thrombosis and pulmonary embolism. Current evidence supports a risk-stratified approach combining mechanical and pharmacologic prophylaxis tailored to patient-specific and procedural risk factors. Low-molecular-weight heparin (LMWH) or unfractionated heparin are commonly recommended agents, with timing and duration individualized based on surgery type and bleeding risk. Despite established guidelines, variability in practice persists, underscoring the need for ongoing evaluation of prophylaxis protocols to optimize safety and efficacy.
What the evidence shows
VTE is a well-recognized complication after general surgical procedures, with risk influenced by patient factors (age, comorbidities, prior VTE) and surgical factors (procedure type, duration, invasiveness). The CAPRINI risk assessment model remains a validated tool to stratify patients and guide prophylaxis intensity (Caprini et al., 2007). Mechanical methods such as intermittent pneumatic compression devices are recommended universally in the perioperative period, especially when pharmacologic agents are contraindicated.
Pharmacologic prophylaxis with LMWH or unfractionated heparin has demonstrated efficacy in reducing postoperative VTE incidence without substantially increasing bleeding risk when appropriately timed (Jibawi et al., 2018; Chen et al., 2020). Early initiation, typically within 12 to 24 hours postoperatively, balances thrombosis prevention and hemorrhagic complications. Extended prophylaxis beyond hospital discharge may benefit high-risk patients undergoing major abdominal or pelvic surgery, although optimal duration remains debated.
Minimally invasive surgical approaches may reduce VTE risk compared to open procedures, but prophylaxis guidelines remain consistent regardless of technique (Jorgensen et al., 2019). Evidence from other surgical specialties, such as urology and thoracic surgery, reinforces the importance of individualized prophylaxis plans integrating patient risk and procedural factors (Klaassen et al., 2020; Batchelor et al., 2019).
Caveats and uncertainty
Most data derive from heterogeneous surgical populations and extrapolation from specialty-specific studies; direct randomized controlled trials in general surgery remain limited. Bleeding risk assessment is complex, and balancing thromboprophylaxis against hemorrhagic complications requires clinical judgment. The ideal duration of prophylaxis, particularly post-discharge, is not definitively established and may vary by patient risk profile and procedure.
Mechanical prophylaxis adherence can be inconsistent, and its standalone efficacy is inferior to combined regimens. Emerging anticoagulants and dosing strategies warrant further evaluation in the general surgical population. Additionally, the impact of enhanced recovery after surgery (ERAS) protocols on VTE risk and prophylaxis efficacy is an evolving area needing more robust data (Batchelor et al., 2019).
How this may change practice
Surgeons should employ validated risk assessment tools such as the CAPRINI score to individualize VTE prophylaxis strategies. Combining mechanical and pharmacologic methods remains standard, with early initiation of anticoagulation postoperatively unless contraindicated. Awareness of bleeding risk factors and close monitoring are essential to minimize complications.
Enhanced recovery protocols may influence VTE risk profiles and prophylaxis timing, suggesting integration of ERAS principles with thromboprophylaxis planning. Extended prophylaxis should be considered for high-risk patients, with ongoing evaluation of emerging evidence to refine duration and agent selection.
Institutional protocols should emphasize adherence to prophylaxis guidelines, patient education, and multidisciplinary coordination to optimize outcomes. Future research is needed to clarify prophylaxis duration, novel agents’ roles, and tailored approaches in minimally invasive surgery.